awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36066514-202D0FDC-4F1B-4981-AFCB-9F4D5B7E71BA
Q36066514-202D0FDC-4F1B-4981-AFCB-9F4D5B7E71BA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36066514-202D0FDC-4F1B-4981-AFCB-9F4D5B7E71BA
Randomized trial comparing dose reduction and growth factor supplementation for management of hematological side effects in HIV/hepatitis C virus patients receiving pegylated-interferon and ribavirin
P2860
Q36066514-202D0FDC-4F1B-4981-AFCB-9F4D5B7E71BA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36066514-202D0FDC-4F1B-4981-AFCB-9F4D5B7E71BA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a5d71b1900abd4eb9cf55811accb0c56e38e0bd3
P2860
Pegylated interferon alpha2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients.